BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6577475)

  • 1. Persistent pulmonary hypertension and prostaglandin D2.
    Philips JB; Lyrene RK
    Prog Clin Biol Res; 1983; 127():21-32. PubMed ID: 6577475
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandins, related compounds, and the perinatal pulmonary circulation.
    Philips JB; Lyrene RK
    Clin Perinatol; 1984 Oct; 11(3):565-79. PubMed ID: 6386270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension.
    Soifer SJ; Clyman RI; Heymann MA
    J Pediatr; 1988 May; 112(5):774-7. PubMed ID: 3162978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent pulmonary hypertension of the neonate (persistent fetal circulation syndrome).
    Drummond WH
    Adv Pediatr; 1983; 30():61-91. PubMed ID: 6424420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin D2 reverses induced pulmonary hypertension in the newborn lamb.
    Soifer SJ; Morin FC; Heymann MA
    J Pediatr; 1982 Mar; 100(3):458-63. PubMed ID: 7199569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction of tolazoline and cimetidine in persistent fetal circulation of the newborn infant].
    Roll C; Hanssler L
    Monatsschr Kinderheilkd; 1993 Apr; 141(4):297-9. PubMed ID: 8487790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn.
    Turner GR; Levin DL
    Clin Perinatol; 1984 Oct; 11(3):581-9. PubMed ID: 6488671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tolazoline and dopamine in the treatment of the persistent fetal circulation syndrome].
    Seri I; Tulassay TL; Machay T; Kiszel J; Téglás E; Csömör S
    Monatsschr Kinderheilkd; 1983 Oct; 131(10):710-3. PubMed ID: 6646141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tolazoline and dopamine in the management of persistent fetal circulation].
    Seri I; Tulassay T; Kiszel J; Machay T; Lipták M; Csömör S
    Orv Hetil; 1984 Aug; 125(32):1939-40, 1943-44. PubMed ID: 6382116
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolazoline therapy in newborns with persistent pulmonary hypertension.
    Liao MF; Liang IS; Tsao LY; Eitzman DV
    Taiwan Yi Xue Hui Za Zhi; 1984 Mar; 83(3):299-306. PubMed ID: 6588141
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of indomethacin and prostaglandins E2, I2, and D2 on the fetal circulation.
    Sideris EB; Yokochi K; Van Helder T; Coceani F; Olley PM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():477-82. PubMed ID: 6221634
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolazoline HCl (Priscoline).
    Noerr B
    Neonatal Netw; 1988 Dec; 7(3):74-5. PubMed ID: 3205245
    [No Abstract]   [Full Text] [Related]  

  • 14. The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb.
    Soifer SJ; Morin FC; Kaslow DC; Heymann MA
    J Dev Physiol; 1983 Aug; 5(4):237-50. PubMed ID: 6579103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.
    Kulik TJ; Lock JE
    Clin Perinatol; 1984 Oct; 11(3):693-701. PubMed ID: 6488673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing care of the infant with persistent pulmonary hypertension of the newborn.
    Beachy P; Powers LK
    Clin Perinatol; 1984 Oct; 11(3):681-92. PubMed ID: 6386272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolazoline in the treatment of congenital diaphragmatic hernias.
    Sumner E; Frank JD
    Arch Dis Child; 1981 May; 56(5):350-3. PubMed ID: 6789778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin D2, a potential antineoplastic agent.
    Fukushima M; Kato T; Ueda R; Ota K; Narumiya S; Hayaishi O
    Biochem Biophys Res Commun; 1982 Apr; 105(3):956-64. PubMed ID: 6953969
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of prostacyclin in persistent fetal circulation.
    Cassin S; Tod ML; Frisinger JE; Jordan JA; Philips JB
    Lancet; 1979 Sep; 2(8143):638. PubMed ID: 90302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Persistent fetal circulation diagnosed with echocardiographic contrast studies].
    Cats BP; Gerards LJ; van Ertbruggen I; Senders RC
    Ned Tijdschr Geneeskd; 1980 Sep; 124(36):1489-92. PubMed ID: 7412932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.